세계의 바이러스 벡터 위탁개발생산(CDMO) 시장 보고서(2025년)

A viral vector contract development and manufacturing organization (CDMO) is a specialized company that focuses on the development and large-scale production of viral vectors used in advanced biological therapies. It provides the necessary technical expertise, infrastructure, and regulatory compliance to support the complete viral vector manufacturing process.

The primary services offered by viral vector CDMOs include process development, manufacturing, analytical testing, fill-finish, and more. Process development in pharmaceutical manufacturing involves designing and optimizing production processes to ensure efficient, scalable, and reproducible outcomes. The different vector types include adenoviral vectors, lentiviral vectors, adeno-associated viral vectors, retroviral vectors, and others, with workflows covering upstream and downstream manufacturing. These services are applied in gene therapy, vaccines, cell therapy, and other areas, and the key end-users include pharmaceutical and biotechnology companies, academic and research institutes, and additional organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The viral vector contract development and manufacturing organization (CDMO) market research report is one of a series of new reports from The Business Research Company that provides viral vector contract development and manufacturing organization (CDMO) market statistics, including viral vector contract development and manufacturing organization (CDMO) industry global market size, regional shares, competitors with a viral vector contract development and manufacturing organization (CDMO) market share, detailed viral vector contract development and manufacturing organization (CDMO) market segments, market trends and opportunities, and any further data you may need to thrive in the viral vector contract development and manufacturing organization (CDMO) industry. This viral vector contract development and manufacturing organization (CDMO) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The viral vector contract development and manufacturing organization (CDMO) market size has grown rapidly in recent years. It will grow from $1.27 billion in 2024 to $1.47 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth during the historic period can be attributed to the increasing number of gene therapy and cell therapy clinical programs, rising healthcare expenditure, early regulatory approvals supporting viral vector therapeutics, growing investments in specialized facilities, and dependence on plasmid DNA supply.

The viral vector contract development and manufacturing organization (CDMO) market size is expected to see rapid growth in the next few years. It will grow to $2.61 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%. The growth during the forecast period can be attributed to the commercialization of more gene therapies for both common and rare diseases, rapid expansion of outsourced capacity and CDMO investments, regulatory harmonization, increasing demand for on-demand, personalized, and autologous manufacturing, and the rising prevalence of chronic diseases. Key trends in the forecast period include consolidation and vertical integration among large CDMOs and biopharma companies, regional capacity expansion, ongoing focus on cost reduction through process optimization and economies of scale, diversification into plasmid DNA, non-viral platforms, and fill-finish services, and adoption of digital or AI-enabled monitoring and quality control.

The growing investment in gene therapy research is expected to drive the growth of the viral vector contract development and manufacturing organization (CDMO) market in the coming years. Gene therapy research focuses on methods to modify or regulate genes in human cells to correct genetic disorders or treat various diseases. Investment in this area is increasing due to the potential of gene therapies to provide long-term or permanent cures for previously untreatable genetic conditions, attracting strong interest from healthcare innovators and investors. Viral vector CDMOs support gene therapy research by providing specialized expertise and advanced production facilities to manufacture high-quality viral vectors, which are essential for the safe and effective delivery of therapeutic genes. For example, in July 2025, the UK's Office for Life Sciences reported a government commitment of up to $800 million (£600 million) to develop a secure, AI-compatible health data platform integrating genomic, diagnostic, and clinical information at a population level, aiming to transform NHS and global healthcare data into a hub for research trials and AI investment. Therefore, rising investment in gene therapy research is fueling the growth of the viral vector CDMO market.

Leading companies in the viral vector CDMO market are advancing viral vector manufacturing solutions to support scalable and efficient gene therapy production. AAV manufacturing solutions, for instance, involve systems and techniques developed to efficiently produce safe and effective adeno-associated virus vectors for gene therapy. In August 2025, ProBio, a US-based CDMO, launched cGMP AAV manufacturing services at its 128,000 sq. ft. facility in Hopewell, New Jersey. This expansion meets the growing demand for high-quality viral vector production and demonstrates ProBio's commitment to supporting innovative gene therapies. The Hopewell facility provides fully integrated services including GMP plasmid DNA production, AAV vector manufacturing, and final drug product formulation with aseptic fill-finish, all in one location. This integrated approach improves coordination, reduces process handoffs, and accelerates timelines across the drug development lifecycle.

In May 2023, Siegfried, a Switzerland-based life sciences company, acquired a 95% stake in DINAMIQS for an undisclosed amount. This acquisition allows Siegfried to scale DINAMIQS' capabilities to commercial levels, positioning it as a leading biotech CDMO for cell and gene therapies. The move strengthens Siegfried's presence in the biologics sector and is expected to create significant mid- to long-term growth opportunities in this rapidly evolving market. DINAMIQS provides comprehensive contract development and manufacturing services for viral vectors.

Major players in the viral vector contract development and manufacturing organization (CDMO) market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, WuXi AppTec, Samsung Biologics Co. Ltd., FUJIFILM Biotechnologies, Oxford Biomedica Plc, Hillgene, Takara Bio Inc., SkyPharma Production SAS, GeneScript ProBio, Obio Technology Corp. Ltd., VectorBuilder, Charles River Laboratories Pvt. Ltd., Creative Biogene, Esco Aster Pte. Ltd., Genesail Biotech Co. Ltd., CEVEC Pharmaceuticals, Cell and Gene Therapy Catapult, CoJourney, and Applied Biological Laboratories Inc.

North America was the largest region in the viral vector contract development and manufacturing organization (CDMO) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in viral vector contract development and manufacturing organization (CDMO) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the viral vector contract development and manufacturing organization (CDMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viral vector contract development and manufacturing organization (CDMO) market consists of revenues earned by entities by providing services such as cell line development, preclinical material production, quality control testing, and supply chain management. The market value includes the value of related goods sold by the service provider or included within the service offering. The viral vector contract development and manufacturing organization (CDMO) market also includes sales of helper plasmids, packaging cell lines, producer cell banks, and purified viral vector components. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viral Vector Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viral vector contract development and manufacturing organization (cdmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viral vector contract development and manufacturing organization (cdmo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral vector contract development and manufacturing organization (cdmo) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service Type: Process Development; Manufacturing; Analytical Testing; Fill-Finish; Other Service Types
• 2) By Vector Type: Adenoviral Vectors; Lentiviral Vectors; Adeno-Associated Viral Vectors; Retroviral Vectors; Other Vector Types
• 3) By Workflow: Upstream Manufacturing; Downstream Manufacturing
• 4) By Application: Gene Therapy; Vaccines; Cell Therapy; Other Applications
• 5) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Other End-Users
• Subsegments:
• 1) By Process Development: Upstream Process Development; Downstream Process Development; Analytical Development; Process Characterization
• 2) By Manufacturing: Clinical Manufacturing; Commercial Manufacturing; cGMP Manufacturing; Cell Bank Production; Fill-Finish Services
• 3) By Analytical Testing: Release Testing; Stability Testing; Bioassays; Characterization Studies; Regulatory Compliance Testing
• 4) By Fill-Finish: Aseptic Filling; Lyophilization; Final Packaging; Cold Chain Management; Labeling And Serialization
• 5) By Other Service Types: Regulatory Support; Supply Chain Management; Technology Transfer; Clinical Trial Support; Cold Chain Logistics
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Lonza Group AG; WuXi AppTec; Samsung Biologics Co. Ltd.; FUJIFILM Biotechnologies; Oxford Biomedica Plc; Hillgene; Takara Bio Inc.; SkyPharma Production SAS; GeneScript ProBio; Obio Technology Corp. Ltd.; VectorBuilder; Charles River Laboratories Pvt. Ltd.; Creative Biogene; Esco Aster Pte. Ltd.; Genesail Biotech Co. Ltd.; CEVEC Pharmaceuticals; Cell and Gene Therapy Catapult; CoJourney; Applied Biological Laboratories Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Characteristics

3. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies

4. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Growth Rate Analysis
• 5.4. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM)

6. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Segmentation

• 6.1. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Process Development
• Manufacturing
• Analytical Testing
• Fill-Finish
• Other Service Types
• 6.2. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adenoviral Vectors
• Lentiviral Vectors
• Adeno-Associated Viral Vectors
• Retroviral Vectors
• Other Vector Types
• 6.3. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Upstream Manufacturing
• Downstream Manufacturing
• 6.4. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapy
• Vaccines
• Cell Therapy
• Other Applications
• 6.5. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Academic And Research Institutes
• Other End-Users
• 6.6. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Process Development, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Upstream Process Development
• Downstream Process Development
• Analytical Development
• Process Characterization
• 6.7. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Manufacturing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Manufacturing
• Commercial Manufacturing
• cGMP Manufacturing
• Cell Bank Production
• Fill-Finish Services
• 6.8. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Analytical Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Release Testing
• Stability Testing
• Bioassays
• Characterization Studies
• Regulatory Compliance Testing
• 6.9. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Fill-Finish, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aseptic Filling
• Lyophilization
• Final Packaging
• Cold Chain Management
• Labeling and Serialization
• 6.10. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Other Service Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Regulatory Support
• Supply Chain Management
• Technology Transfer
• Clinical Trial Support
• Cold Chain Logistics

7. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis

• 7.1. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 8.1. Asia-Pacific Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 9.1. China Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
• 9.2. China Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 10.1. India Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 11.1. Japan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
• 11.2. Japan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 12.1. Australia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 13.1. Indonesia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 14.1. South Korea Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
• 14.2. South Korea Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 15.1. Western Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
• 15.2. Western Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 16.1. UK Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 17.1. Germany Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 18.1. France Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 19.1. Italy Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 20.1. Spain Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 21.1. Eastern Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
• 21.2. Eastern Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 22.1. Russia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 23.1. North America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
• 23.2. North America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 24.1. USA Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
• 24.2. USA Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 25.1. Canada Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
• 25.2. Canada Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 26.1. South America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
• 26.2. South America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 27.1. Brazil Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 28.1. Middle East Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
• 28.2. Middle East Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

• 29.1. Africa Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
• 29.2. Africa Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles

• 30.1. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape
• 30.2. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. WuXi AppTec Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Samsung Biologics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies

• 31.1. FUJIFILM Biotechnologies
• 31.2. Oxford Biomedica Plc
• 31.3. Hillgene
• 31.4. Takara Bio Inc.
• 31.5. SkyPharma Production SAS
• 31.6. GeneScript ProBio
• 31.7. Obio Technology Corp. Ltd.
• 31.8. VectorBuilder
• 31.9. Charles River Laboratories Pvt. Ltd.
• 31.10. Creative Biogene
• 31.11. Esco Aster Pte. Ltd.
• 31.12. Genesail Biotech Co. Ltd.
• 31.13. CEVEC Pharmaceuticals
• 31.14. Cell and Gene Therapy Catapult
• 31.15. CoJourney

32. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

34. Recent Developments In The Viral Vector Contract Development And Manufacturing Organization (CDMO) Market

35. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies

• 35.1 Viral Vector Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Viral Vector Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Viral Vector Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer